Compare RDY & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | DPZ |
|---|---|---|
| Founded | 1984 | 1960 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 11.6B |
| IPO Year | 2001 | 2004 |
| Metric | RDY | DPZ |
|---|---|---|
| Price | $12.50 | $307.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 30 |
| Target Price | $13.22 | ★ $372.96 |
| AVG Volume (30 Days) | ★ 2.9M | 686.8K |
| Earning Date | 10-23-2026 | 10-13-2026 |
| Dividend Yield | 0.53% | ★ 2.58% |
| EPS Growth | N/A | ★ 5.27 |
| EPS | N/A | ★ 8.21 |
| Revenue | N/A | ★ $4,939,994,000.00 |
| Revenue This Year | $4.75 | $4.93 |
| Revenue Next Year | $11.72 | $2.27 |
| P/E Ratio | ★ $18.67 | $37.59 |
| Revenue Growth | N/A | ★ 4.96 |
| 52 Week Low | $11.36 | $282.00 |
| 52 Week High | $15.67 | $442.35 |
| Indicator | RDY | DPZ |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 48.99 |
| Support Level | $12.09 | $297.56 |
| Resistance Level | $12.48 | $322.12 |
| Average True Range (ATR) | 0.22 | 7.08 |
| MACD | -0.00 | 2.72 |
| Stochastic Oscillator | 48.00 | 87.24 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.